Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

NCT00338390 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir
DRUG: Didanosine
DRUG: Abacavir+Lamivudine

Sponsor

Hospital de Granollers